Edwards Lifesciences Corp Cash Flow-to-Debt Ratio
Edwards Lifesciences Corp cash flow-to-debt ratio. Edwards Lifesciences Corp (EW) has a Cash Flow-to-Debt Ratio of 0.21x as of June 2026, meaning its operating cash flow of $651.90 Million could theoretically repay 0% of its total liabilities ($3.14 Billion) in one year. Check Edwards Lifesciences Corp cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Edwards Lifesciences Corp (1999–2025)
Cash flow-to-debt ratio of Edwards Lifesciences Corp from 1999 to 2025. Historical debt coverage capacity for Edwards Lifesciences Corp across 27 annual periods. Check Edwards Lifesciences Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Edwards Lifesciences Corp Cash Flow-to-Debt Ratio by Year (1999–2025)
Edwards Lifesciences Corp cash flow-to-debt ratio by year from 1999 to 2025. Year-by-year debt coverage analysis for Edwards Lifesciences Corp. For the full cash flow conversion analysis, see EW cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.47x | $1.60 Billion | $3.36 Billion | ▲ +162.0% |
| 2024 | 0.18x | $542.30 Million | $2.99 Billion | ▼ -46.5% |
| 2023 | 0.34x | $895.80 Million | $2.64 Billion | ▼ -30.9% |
| 2022 | 0.49x | $1.22 Billion | $2.49 Billion | ▼ -24.6% |
| 2021 | 0.65x | $1.73 Billion | $2.67 Billion | ▲ +64.0% |
| 2020 | 0.40x | $1.05 Billion | $2.66 Billion | ▼ -21.5% |
| 2019 | 0.50x | $1.18 Billion | $2.34 Billion | ▲ +18.7% |
| 2018 | 0.42x | $926.80 Million | $2.18 Billion | ▲ +14.6% |
| 2017 | 0.37x | $1.00 Billion | $2.70 Billion | ▼ -0.6% |
| 2016 | 0.37x | $704.40 Million | $1.89 Billion | ▲ +5.5% |
| 2015 | 0.35x | $549.70 Million | $1.56 Billion | ▼ -53.9% |
| 2014 | 0.77x | $1.02 Billion | $1.33 Billion | ▲ +89.1% |
| 2013 | 0.41x | $472.70 Million | $1.17 Billion | ▼ -19.5% |
| 2012 | 0.50x | $373.80 Million | $742.20 Million | ▲ +2.9% |
| 2011 | 0.49x | $314.50 Million | $642.60 Million | ▼ -10.6% |
| 2010 | 0.55x | $251.40 Million | $459.00 Million | ▲ +51.6% |
| 2009 | 0.36x | $165.30 Million | $457.60 Million | ▲ +22.9% |
| 2008 | 0.29x | $153.20 Million | $521.40 Million | ▼ -28.7% |
| 2007 | 0.41x | $210.20 Million | $510.10 Million | ▼ -11.2% |
| 2006 | 0.46x | $230.80 Million | $497.40 Million | ▲ +82.9% |
| 2005 | 0.25x | $136.80 Million | $539.10 Million | ▼ -31.9% |
| 2004 | 0.37x | $180.60 Million | $484.60 Million | ▲ +42.1% |
| 2003 | 0.26x | $122.30 Million | $466.30 Million | ▲ +2.0% |
| 2002 | 0.26x | $120.60 Million | $468.80 Million | ▲ +30.9% |
| 2001 | 0.20x | $101.00 Million | $514.00 Million | ▼ -7.1% |
| 2000 | 0.21x | $137.00 Million | $648.00 Million | ▼ -74.4% |
| 1999 | 0.83x | $176.00 Million | $213.00 Million | — |